Hepatitis C: Hunting the silent killer
A disease could now be eradicated
The Guardian "More than 150 million people worldwide could have highly infectious hepatitis C without realising. There is a cure, but how will doctors find the people who need it?" Patrick Strudwick investigates in an article first published in Mosaic.
Pharma accused of restricting access to hep C drug in poor countries
Sarah Bosley in The Guardian
The Guardian "New drugs for hepatitis C are a major breakthrough but hugely expensive in rich countries. Pharma giant Gilead will allow cheap copies to be made for poor countries - but only for patients with proof of identification and citizenship and the drug supplies will be closely tracked." (Photo: Médecins du Monde à Barmane/Frédéric de La Mure, MAEDI)